Literature DB >> 16997142

The therapeutic potential of the calpain family: new aspects.

Maria E Saez1, Reposo Ramirez-Lorca, Francisco J Moron, Agustin Ruiz.   

Abstract

The calpain family is a group of cysteine proteases unique in their dependency on calcium to attain functionally active forms. Calpains are involved in a wide range of cellular calcium-regulated functions, including signal transduction, cell proliferation and differentiation, and apoptosis. Moreover, altered calpain activity has been observed in several human diseases. Specific calpain inhibitors hold promise for the treatment of neuromuscular and neurodegenerative diseases in which calpains have been shown to be upregulated (e.g. Parkinson's disease and Duchenne muscular dystrophy). Conversely, calpain activators could be a useful approach for those diseases where reduced calpain activity has been observed, such as type 2 diabetes or metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997142     DOI: 10.1016/j.drudis.2006.08.009

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  44 in total

1.  Calpain plays a central role in 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in cerebellar granule neurons.

Authors:  Richard A Harbison; Kristen R Ryan; Heather M Wilkins; Emily K Schroeder; F Alexandra Loucks; Ron J Bouchard; Daniel A Linseman
Journal:  Neurotox Res       Date:  2010-03-24       Impact factor: 3.911

2.  Neurite consolidation is an active process requiring constant repression of protrusive activity.

Authors:  Ana Mingorance-Le Meur; Timothy P O'Connor
Journal:  EMBO J       Date:  2008-12-18       Impact factor: 11.598

3.  Critical role of calpain in inflammation.

Authors:  Jingjing Ji; Lei Su; Zhifeng Liu
Journal:  Biomed Rep       Date:  2016-10-19

4.  RPF151, a novel capsaicin-like analogue: in vitro studies and in vivo preclinical antitumor evaluation in a breast cancer model.

Authors:  Adilson Kleber Ferreira; Maurício Temotheo Tavares; Kerly Fernanda Mesquita Pasqualoto; Ricardo Alexandre de Azevedo; Sarah Fernandes Teixeira; Wilson Alves Ferreira-Junior; Ariane Matiello Bertin; Paulo Luiz de-Sá-Junior; José Alexandre Marzagão Barbuto; Carlos Rogério Figueiredo; Yara Cury; Mariana Celestina Frojuello Costa Bernstorff Damião; Roberto Parise-Filho
Journal:  Tumour Biol       Date:  2015-04-20

5.  A novel strategy for therapeutic intervention for the genetic disease: preventing proteolytic cleavage using small chemical compound.

Authors:  Masami Yamada; Shinji Hirotsune; Anthony Wynshaw-Boris
Journal:  Int J Biochem Cell Biol       Date:  2010-06-09       Impact factor: 5.085

Review 6.  Co-conspirators in a new mechanism for the degradation of Δ9-desaturase.

Authors:  Sabrina Dumas; James M Ntambi
Journal:  J Biol Chem       Date:  2017-12-08       Impact factor: 5.157

Review 7.  Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.

Authors:  D Morin; R Assaly; S Paradis; A Berdeaux
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

8.  Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis.

Authors:  Roberto Stifanese; Monica Averna; Roberta De Tullio; Marco Pedrazzi; Francesco Beccaria; Franca Salamino; Marco Milanese; Giambattista Bonanno; Sandro Pontremoli; Edon Melloni
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

Review 9.  Tau-based treatment strategies in neurodegenerative diseases.

Authors:  Anja Schneider; Eckhard Mandelkow
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

Review 10.  Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.

Authors:  P S Vosler; C S Brennan; J Chen
Journal:  Mol Neurobiol       Date:  2008-08-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.